Skip to main content
Michalski JM on Muck Rack

Michalski JM

As seen in: Sparda-Bank web.Börsenforum
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michalski

Contact Michalski, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Berliner Volksbank eG

|
By Tepper JE, Michalski JM, eds. Gunderson, Tepper's Clinical
| Sparda-Bank web.Börsenforum
Ad hoc announcement pursuant to Art.
Open in Who Shared View Duplicates (38) Issue with article?

PSD Bank Rhein-Ruhr eG

|
By Gustafsson BI, Tepper JE, Michalski JM, eds. Gunderson
| Sparda-Bank web.Börsenforum
* In the Phase III NETTER-2 trial, Lutathera plus octreotide LAR significantly extended median PFS to 22.8 months vs.
Open in Who Shared View Duplicates (19) Issue with article?

PSD Bank Rhein-Ruhr eG

|
By Tepper JE, Michalski JM, eds. Gunderson, Tepper's Clinical
| Sparda-Bank web.Börsenforum
* FDA approval of the company's second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and beyond * New 70,000-square foot RLT facility is the company's largest and most advanced in the world to date and centrally located in the US to maximize access for patients and treatment centers * With four active RLT manufacturing sites and unconstrained supply, Novartis can sufficiently meet current and future demand as ongoing clinical...
Open in Who Shared View Duplicates (149) Issue with article?
See all 6 articles